Clinical Trial Update: Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial comparing cetuximab maintenance treatment to continuation after induction therapy in metastatic colorectal cancer is in Phase 2/3 with status u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Ruijin Hospital | Conditions: Colorectal Cancer | Phase 2, Phase 3 | Status: UNKNOWN